REPLIGEN CORP (RGEN) Stock News

USA - NASDAQ:RGEN - US7599161095 - Common Stock

152.37 USD

+1.81 (+1.2%)

Last: 11/14/2025, 8:23:06 PM

152.37 USD

0 (0%)

After Hours: 11/14/2025, 8:23:06 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

RGEN Latest News, Press Relases and Analysis

All

Press Releases

20 days ago - By: Chartmill

News Image

Repligen Corp (NASDAQ:RGEN) Posts Strong Q3 2025 Results, Beating Revenue and EPS Estimates

13 days ago - By: Repligen Corporation

Repligen Corporation to Present at Upcoming November Conferences

20 days ago - By: Repligen Corporation

Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance

25 days ago - By: Zacks Investment Research - Mentions: APLS

Apellis Pharmaceuticals, Inc. (APLS) Reports Next Week: Wall Street Expects Earnings Growth

a month ago - By: Repligen Corporation

Repligen to Report Third Quarter 2025 Financial Results

2 months ago - By: Benzinga

What 8 Analyst Ratings Have To Say About Repligen

2 months ago - By: Benzinga

Analyst Expectations For Repligen's Future

3 months ago - By: Repligen Corporation

Repligen Corporation to Present at Upcoming September Conferences

3 months ago - By: Zacks Investment Research

Do Options Traders Know Something About Repligen Stock We Don't?